Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis

Alternate title: 
J2 - Amyotroph
Secondary title: 
T2 - Amyotrophic Lateral Sclerosis
Short title: 
Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis
Authors: 
Oliver, David J.
Campbell, Colin
O'Brien, Tony
Sloan, Richard
Sykes, Nigel
Tallon, Carol
Taylor-Horan, Jane
Udoma, Mayen
Volume: 
11
Start page: 
562-4
Annotations: 
Type D, Priority 5
Date: 
Dec
Year: 
2010
Accession number: 
20565331
Database: 
MEDLINE Cohort
Number: 
M1 - 6
Serial: 
1471-180X
ID: 
12956
DOI: 
http://dx.doi.org/10.3109/17482968.2010.493203
Notes: 
N1 - Oliver DJ Campbell C O'brien T Sloan R Sykes N Tallon C Taylor-Horan J Udoma M
Key words: 
Adult
Aged
Aged, 80 and over
*Amyotrophic Lateral Sclerosis/dt [Drug Therapy]
Analgesics, Opioid/tu [Therapeutic Use]
Anti-Anxiety Agents/tu [Therapeutic Use]
Cholinergic Antagonists/tu [Therapeutic Use]
Death
Female
Great Britain
Hospices
Humans
Ireland
Male
Midazolam/tu [Therapeutic Use]
Middle Aged
*Motor Neuron Disease/dt [Drug Therapy]
*Palliative Care
Retrospective Studies
0 (Analgesics, Opioid)
0 (Anti-Anxiety Agents)
0 (Cholinergic Antagonists)
R60L0SM5BC (Midazolam)
Types of evidence: 
Type D
Priorities of Care: 
Priority 5: Plan and do